Literature DB >> 2996529

In vitro metabolism of [3H]-peptide leukotrienes in human and ferret lung: a comparison with the guinea pig.

D Aharony, P T Dobson, R D Krell.   

Abstract

Fragmented lung tissue prepared from human, ferret and guinea pig converted [3H]-leukotriene C4 ([3H]-LTC4) to [3H]-LTD4 and [3H]-LTE4. [3H]-LTD4 was the major product recovered from incubations with human and guinea pig lung, whereas [3H]-LTE4 was the predominant metabolite in ferret. Kinetic analysis in human lung yielded a much faster rate for the conversion of [3H]-LTC4 to [3H]-LTD4+E4 than for the conversion of [3H]-LTD4 to [3H]-LTE4. In all three species serine-borate complex blocked the metabolism of [3H]-LTC4, whereas L-cysteine blocked the metabolism of [3H]-LTD4. These studies demonstrate that guinea-pig and human lungs have a similar metabolic pattern and capacity which is dissimilar to the ferret.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996529     DOI: 10.1016/0006-291x(85)91323-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.

Authors:  M N Samhoun; D M Conroy; P J Piper
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

2.  Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm.

Authors:  N Minami; E Tani; M Yokota; Y Maeda; I Yamaura
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Effects of L-serine borate on antagonism of leukotriene C4-induced contractions of guinea-pig trachea.

Authors:  L Charette; T R Jones
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

4.  Leukotrienes in the sputum and urine of cystic fibrosis children.

Authors:  A P Sampson; D A Spencer; C P Green; P J Piper; J F Price
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.